Side-Effects of COVID-19 on Patient Care: An INR Story.

Lauren N PearsonStacy A JohnsonDina N GreeneAllison B ChamblissChristopher W FarnsworthDeborah FrenchDaniel S HermanPeter A KavsakAnna E MerrillSheng-Ying Margaret LoMartha E LyonJeffrey A SoRelleRobert L Schmidt

Published in: The journal of applied laboratory medicine (2021)

The COVID-19 pandemic impacted INR testing among outpatients which may be attributable to several factors. Increased supratherapeutic INR results during the pandemic period when there was reduced laboratory utilization and access to care is concerning because of the risk of adverse bleeding events in this group of patients. This could be mitigated in the future by offering drive-through testing and/or widespread implementation of home INR monitoring.

Keyphrases

coronavirus disease
healthcare
sars cov
end stage renal disease
newly diagnosed
ejection fraction
quality improvement
primary care
palliative care
prognostic factors
atrial fibrillation
emergency department